Published • loading... • Updated
Magnetite-Silica Core-Shell Nanoparticles for Anticancer Drug-Mediated Chemo-Hyperthermia: A Box-Behnken Design Approach to Triple-Negative Breast Cancer Therapy
Summary by Pharma Excipients
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Magnetite-Silica Core-Shell Nanoparticles for Anticancer Drug-Mediated Chemo-Hyperthermia: A Box-Behnken Design Approach to Triple-Negative Breast Cancer Therapy
Abstract Triple negative breast cancer (TNBC) is one of the most aggressive breast cancer subtypes that is characterized by the lack of clinical targets and the resistance of conventional chemotherapy. We have developed cyclophosphamide loaded magnetic mesoporous nanoparticles (CYP-MMNPs) and optimized the formulation systematically by Box – Behnken Design (BBD) coupled with Response Surface Methodology […] Der Beitrag Magnetite-Silica Core-Shel…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
